Research into conolidine has brought about discovery of an opioid receptor in the body identified as ACKR3/CXCR7. ACKR3 is apparently the most desired target for conolidine, which also disregards the other 4 classical opioid receptors(3). There is certainly fascination in working with conolidine for a pain-reliever according to evidence https://kylerijarf.blogerus.com/60151648/the-basic-principles-of-alternative-natural-pain-relief-to-replace-traditional-painkillers